A 12-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Citicoline as an Add-on Therapy Will be Conducted in 200 Outpatients With Bipolar I Disorder and Cocaine Dependence.

Trial Profile

A 12-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Citicoline as an Add-on Therapy Will be Conducted in 200 Outpatients With Bipolar I Disorder and Cocaine Dependence.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2015

At a glance

  • Drugs Citicoline (Primary)
  • Indications Bipolar I disorders; Cocaine abuse
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 15 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top